Conference abstract · 17 Jun 2021
Conference abstractPublished 2020
Medication Safety during COVID 19
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The COVID-19 pandemic and the response of the healthcare system has affected the ability of healthcare to ensure medication safety in several ways. These include challenges associated with medication shortages, changes to the pharmacy workflow, an ever-changing evidence base associated with the pharmaceutical treatment of COVID-19 complications, and limited availability of personal protective equipment (PPE). Pharmacists are the best-positioned professionals to ensure safety through the preparation, delivery, and ongoing management of medications. However, like the majority of healthcare providers, the usual pharmacy workflow and operations have been greatly impacted by the response to COVID-19 have modified the physical settings of care for pharmacists, necessitating changes to their workflows. Additionally, pharmacist workflows may be interrupted or require modification due to increased informatics and technology changes associated with monitoring medication supplies or when systems are operating with a decreased workforce (colleagues are forced to work from home, are sick, or may be furloughed). Lastly, redeployment of healthcare personnel to new areas and specialty of care may introduce safety risks due to unfamiliarity with workflows and processes. For example, the Institute for Safe Medication Practices recently shared a case study in which there was a failure to engage barcode medication administration, a best practice in medication safety, when healthcare staff was assigned to a new patient care area. Also the recommendation of using automation during COVID-19.
Keywords
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Article · 2021
Medication Safety During COVID 19
Conference abstract · 2020
Medication Safety during COVID 19
Conference abstract
An example of using a decision making framework designed for non-medical prescribers as a method for enhancing prescribing safety for inhaled corticosteroids (ICS)
Review article · 2020
The Efficacy and Safety of Antivirus Drugs for COVID-19: A Systematic Review
More from this journal
The newest in American Journal of Drug Delivery and Therapeutics.
Article · 20 Jun 2025
NDPS Convictions and Drug De-addiction: The case of Punjab
Article · 1 Apr 2025
Unveiling Pharmacokinetics: The Dynamic Journey of Drugs in the Body
Article · 1 Apr 2025
Innovations in Drug Delivery Systems: Paving the Way for Precision Medicine
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalAmerican Journal of Drug Delivery and Therapeutics
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Fatima Yousef Ghethan”
